← Leaderboards
Wing Pui Kong
National Institute Of Allergy And Infectious Diseases
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute Of Allergy And Infectious Diseases
Same institution · by research overlap
Others in their field
Top investigators on “Pre-Clinical”
- Leonard Freedman · Leidos Biomedical Research, Inc.$264,541,531
- Dennis R. Burton · Scripps Research Institute$257,157,696
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barton F Haynes · Duke University$186,001,832
- David Heimbrook · Leidos Biomedical Research, Inc.$151,740,590
- Reisa A. Sperling · Banner Health$137,047,788
Research focus
Pre-ClinicalVaccinesNanoparticleVaccine DevelopmentImmunizationVaccine CandidateAntibodiesPathogenAntigensVirologyDesignResponseRespiratoryStructure2019-NcovMutationSurfaceNational Institute Of Allergy And Infectious DiseaseCollaborationsCovid-19 VaccineCoronavirusRespiratory VirusBurden Of IllnessImmunocompromised Host
Grant awards (8)
Pre-clinical Vaccine and Antibody Development for Coronavirus Disease$675,181
ZIC · FY2025 · AI · contact PI
Pre-clinical Vaccine and Antibody Development for Coronavirus Disease 2019 (COVID-19)$1,368,169
ZIC · FY2024 · AI · contact PI
Pre-clinical Vaccine Development for Emerging and Re-emerging Infectious Diseases$912,113
ZIC · FY2024 · AI · contact PI
Pre-clinical Vaccine Development for Respiratory Viruses$912,113
ZIC · FY2024 · AI · contact PI
Pre-clinical Vaccine Development for Respiratory Viruses$2,480,852
ZIC · FY2023 · AI · contact PI
Pre-clinical Vaccine Development for Emerging and Re-emerging Infectious Diseases$2,480,852
ZIC · FY2023 · AI · contact PI
Pre-clinical Vaccine and Antibody Development for Coronavirus Disease 2019 (COVID-19)$285,362
ZIC · FY2023 · AI · contact PI
Pre-clinical Vaccine Development for Respiratory Viruses$2,426,352
ZIC · FY2019 · AI · contact PI